Pauline Mary Amuge
Pauline Mary Amuge publishes mostly in Infectious Diseases, Emergency Medicine and Epidemiology, on topics such as HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions and Tuberculosis Research and Epidemiology.
- World rank
- #666,226 of 7,710,434 ranked researchers
- Rank in Uganda
- #301 of 3,724
- Works
- 43
- Citations
- 880
- Citations per work
- 20.5
What does Pauline Mary Amuge research?
Pauline Mary Amuge's work is mostly in Medicine (76%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3375.9%
- Medicine3375.9%
- Everything else716.1%
- Life Sciences38.0%
- 1Infectious Diseases46% of their works
- 2Emergency Medicine10% of their works
- 3Epidemiology10% of their works
- 4Virology8% of their works
- 5Pediatrics, Perinatology and Child Health5% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Tuberculosis Research and Epidemiology
- HIV-related health complications and treatments
- HIV Research and Treatment
- Pneumocystis jirovecii pneumonia detection and treatment
- Maternal and Perinatal Health Interventions
- Global Maternal and Child Health
Which keywords describe Pauline Mary Amuge's research?
The keywords of their largest research topics: Antiretroviral Therapy, Drug Resistance, HIV Infection, Immune Response, Vaccine, Diagnosis, Integrase Inhibitors and Nucleoside Analogues.
- Vaginal Birth
- Child Mortality
- Pneumonia
- Antibodies
- Inflammation
- Tuberculosis
- HIV
- HIV Transmission
- Nucleoside Analogues
- Diagnosis
- Immune Response
- Drug Resistance
- Antiretroviral Therapy
- HIV Infection
- Vaccine
- Integrase Inhibitors
- Treatment
- Preexposure Prophylaxis
- Mycobacterium tuberculosis
- Cardiovascular Disease
- AIDS
- Pneumocystis
- Cesarean Section
- Maternal Mortality
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Antiretroviral Therapy665 topics
- Drug Resistance332 topics
- HIV Infection312 topics
- Immune Response222 topics
- Vaccine222 topics
- Diagnosis202 topics
- Integrase Inhibitors201 topic
- Nucleoside Analogues201 topic
- Treatment202 topics
- HIV Transmission191 topic
- Preexposure Prophylaxis191 topic
- HIV162 topics
- Mycobacterium tuberculosis131 topic
- Tuberculosis131 topic
- Cardiovascular Disease111 topic
- Inflammation111 topic
- AIDS91 topic
- Antibodies91 topic
- Pneumocystis71 topic
- Pneumonia71 topic
- Cesarean Section31 topic
- Child Mortality31 topic
- Maternal Mortality31 topic
- Vaginal Birth31 topic
Where does Pauline Mary Amuge work?
Pauline Mary Amuge's main affiliation in the publication record is Baylor College of Medicine Children’s Foundation, Uganda.
How many publications and citations does Pauline Mary Amuge have?
OpenAlex counts 43 works and 880 citations for Pauline Mary Amuge, an h-index of 17, ranking #666,226 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Pauline Mary Amuge. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.